STOCK TITAN

Mind Medicine Inc - MNMD STOCK NEWS

Welcome to our dedicated news page for Mind Medicine (Ticker: MNMD), a resource for investors and traders seeking the latest updates and insights on Mind Medicine.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Mind Medicine's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Mind Medicine's position in the market.

Rhea-AI Summary
Mind Medicine (MindMed) Inc announced that members of the Company’s management team will participate in investor conferences.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.28%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.52%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.05%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.01%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
MindMed reports financial results for Q1 2023 and provides business update on key milestones. Key readouts for MM-120 in GAD and ADHD expected by end of 2023. MM-402 pre-clinical data to be presented at ASCP 2023 Annual Meeting. Company strengthens leadership team. Cash balance of $129.4 million at March 31, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.8%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.09%
Tags
conferences earnings
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.55%
Tags
conferences
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.94%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.97%
Tags
management
Mind Medicine Inc

Nasdaq:MNMD

MNMD Rankings

MNMD Stock Data

681.74M
33.11M
2.42%
25.4%
10.25%
Medicinal and Botanical Manufacturing
Manufacturing
Link
Canada
Vancouver

About MNMD

Mind Medicine Inc., also known as MindMed, is a New York-based psychedelic medicine biotech company that develops psychedelic-inspired medicines known as psychoplastogens and therapies to address addiction and mental illness.